Literature DB >> 19073203

Disease-oriented approach to botulinum toxin use.

Joseph Jankovic1.   

Abstract

Botulinum toxin (BoNT) has been used for over a quarter of century for the treatment of well over 100 different indications. Many of the symptoms for which BoNT has been found to be effective occur in a variety of neurological disorders. One neurodegenerative disorder in which BoNT has been used extensively to treat various symptoms is Parkinson's disease (PD). This review will highlight the following therapeutic applications of BoNT in conditions associated with PD: limb dystonia, blepharospasm and lid apraxia, bruxism, cervical dystonia (anterocollis), camptocormia, hand and jaw tremor, rigidity (painful shoulder), freezing of gait, sialorrhea, dysphagia (achalasia), seborrhea, hyperhidrosis, overactive bladder, and constipation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073203     DOI: 10.1016/j.toxicon.2008.11.013

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  24 in total

Review 1.  Hand, foot, and spine deformities in parkinsonian disorders.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2019-02-27       Impact factor: 3.575

2.  The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders.

Authors:  María T Gómez-Caravaca; María T Cáceres-Redondo; Ismael Huertas-Fernández; Laura Vargas-González; Fátima Carrillo; Manuel Carballo; Pablo Mir
Journal:  Neurol Sci       Date:  2014-09-20       Impact factor: 3.307

Review 3.  Management of pain in Parkinson's disease.

Authors:  Munazza Sophie; Blair Ford
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

Review 4.  An update on the use of botulinum toxin therapy in Parkinson's disease.

Authors:  Reversa Mills; Laxman Bahroo; Fernando Pagan
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

5.  Flu-like symptoms and associated immunological response following therapy with botulinum toxins.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic; Jordan Feld
Journal:  Neurotox Res       Date:  2013-05-16       Impact factor: 3.911

Review 6.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

7.  Oxybutynin-Induced Hyperthermia in a Patient With Parkinson's Disease.

Authors:  Saad Ahmad; Jonathan Vincent M Reyes; Joseph Lieber
Journal:  Cureus       Date:  2021-04-26

Review 8.  Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.

Authors:  Wolfgang H Jost
Journal:  Toxins (Basel)       Date:  2021-01-25       Impact factor: 4.546

Review 9.  Emerging opportunities for serotypes of botulinum neurotoxins.

Authors:  Zhongxing Peng Chen; J Glenn Morris; Ramon L Rodriguez; Aparna Wagle Shukla; John Tapia-Núñez; Michael S Okun
Journal:  Toxins (Basel)       Date:  2012-11-07       Impact factor: 4.546

Review 10.  Long-term efficacy and safety of botulinum toxin injections in dystonia.

Authors:  Juan Ramirez-Castaneda; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2013-02-04       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.